8 results
10-K
2021 FY
NUVL
Nuvalent Inc - Ordinary Shares
29 Mar 22
Annual report
7:21am
to the amount of drug required to produce a pharmacological effect of given intensity and is not a measure of therapeutic efficacy. All statements … development. Potency as used in this Annual Report refers to the amount of drug required to produce a pharmacological effect of given intensity
424B4
NUVL
Nuvalent Inc - Ordinary Shares
30 Jul 21
Prospectus supplement with pricing info
4:06pm
intensity and is not a measure of therapeutic efficacy. All statements of the potency, selectivity, and brain penetrance of NVL-520 … intensity and is not a measure of therapeutic efficacy. All statements of the potency, selectivity and brain penetrance of NVL-655 in this prospectus
S-1/A
1zxk04rq uw92
22 Jul 21
IPO registration (amended)
6:07am
S-1
01uwbo
7 Jul 21
IPO registration
12:00am
CORRESP
0sdq40la3at4xs69w
6 Jul 21
Correspondence with SEC
12:00am
- Prev
- 1
- Next